2010-03-18 08:58:13 - Stephen Tsang, Associate Director, Edward S. Harkness Eye Institute, Columbia University/New York Presbyterian Hospital will give a Keynote Presentation at GTCbio’s 2nd Annual Ocular Disease Drug & Discovery Conference, May 27 – 28, 2010 in Boston, MA.

Stephen Tsang, Associate Director, Edward S. Harkness Eye Institute, Columbia University/New York Presbyterian Hospital will give a Keynote Presentation on Transplantation of Reprogrammed Embryonic Stem Cells Improves Visual Function in a Mouse Model for Retinitis Pigmentosa at GTCbio’s 2nd Annual Ocular Disease Drug & Discovery Conference on May 27 – 28, 2010 in Boston, MA.

Stephen Tsang will present his recent studies on retinal pigment epithelium. The highlight of his presentation will include how differentiated ES cells could become a new therapeutic approach for diseases such as age-related macular degeneration, and certain forms of retinitis pigmentosa featuring loss of retinal pigmented epithelial cells.

GTCbio’s Ocular Disease conference will also bring together leading academics from Harvard, Columbia University, National Eye Institute as

well as Industries from Pfizer, GlaxoSmithKline, and Genzyme. Updates on the age related macular degeneration, recent drug developments & mechanisms, ocular disease, and future of ocular disease therapeutics will be addressed and discussed.

GTCbio’s 2nd Annual conference on Ocular Disease Drug and Discovery will provide cutting edge information and a chance to exchange ideas from leading experts in the field. Don’t miss this opportunity to register for GTCbio’s 2nd Annual Ocular Disease Drug and Discovery conference. Please check our web for the most up to date information: www.gtcbio.com/conferenceDetails.aspx?id=148